Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.260
+0.110 (3.49%)
At close: Aug 11, 2026, 4:00 PM EDT
3.251
-0.009 (-0.29%)
After-hours: Aug 11, 2026, 7:52 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $579.97 million as of August 11, 2026. Its market cap has decreased by -9.35% in one year.
Market Cap
579.97M
Enterprise Value
597.38M
1-Year Change
-9.35%
Ranking
Category
Stock Price
$3.26
ChartMarket Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $579.97M, a decrease of -64.36%. That is a compound annual growth rate of -23.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 579.97M | -5.59% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 566.66M |
| Contineum Therapeutics | 565.82M |
| Silence Therapeutics | 564.45M |
| 4D Molecular Therapeutics | 561.97M |
| Autolus Therapeutics | 561.56M |
| Sagimet Biosciences | 559.47M |
| Shattuck Labs | 557.47M |
| MapLight Therapeutics | 551.86M |